- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT03624452
Remote Ischaemic Preconditioning Combined With Exercise Training on Vascular Function.
The Effects of 8 Weeks of Remote Ischaemic Preconditioning Combined With Exercise Training on (Cerebro) Vascular Function.
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
A bout of ischaemia using a blood pressure cuff on the upper arm inflated to a pressure of 220 mm Hg for 5 mins followed by reperfusion (deflation of the cuff) is commonly known as remote ischaemic preconditioning (RIPC). Traditionally, RIPC refers to 5 minutes of inflation-5 minutes deflation repeated 4 times. Recent research has investigated the impact of repeated RIPC interventions on cardiovascular health. One previous repeated RIPC intervention, whereby RIPC was performed 3 times per week for eight weeks, identified that RIPC significantly enhanced conduit artery endothelial function and microvascular function.
Exercise training is crucial for a healthy lifestyle, with the World Health Organization recommending that adults aged 18-64 should do at least 150 minutes of moderate aerobic physical activity per week, or at least 75 minutes of vigorous intensity activity. Interestingly, the impact of exercise training on the vasculature is similar to that of repeated RIPC interventions, with reductions in arterial blood pressure, increased in blood flow and improvements in systemic vascular endothelial function. No study has examined if combining exercise and RIPC provides enhanced effects on the vasculature compared to exercise alone.
The aim of this study is to investigate whether combining 8 weeks of exercise and RIPC is more beneficial to systemic vascular function that exercise alone.
Study Type
Enrollment (Actual)
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
Merseyside
-
Liverpool, Merseyside, United Kingdom, L3 5AF
- Research Institute for Sport and Exercise Science, Liverpool John Moores Unversity
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
- Able to provide written consent.
- Males and females 18 to 65 years.
- Body Mass Index >30g/m2 or waist circumference of ≥94cm (male), ≥80cm (female).
- Raised blood pressure systolic >130 or diastolic >85 mmHg or normal
- Diagnosed with high cholesterol by GP or normal
Exclusion Criteria:
- Type 1 or 2 diabetes mellitus
- Previous myocardial infarction, stroke (including TIA) or thrombosis
- Diagnosed with Congestive Heart failure
- Unable to enroll for the duration of the study
- Pregnancy or lactation period
- Smoking
- Any arm injury that will prevent application of the RIPC-intervention
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Other
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Single
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: rIPC and exercise training
Those in the rIPC + exercise group will attend three 50 minute exercise sessions per week for 8 weeks at Liverpool John Moores University and 3 bouts of IPC per week at home at a time of their choice
|
The interventions consist of exercise training on a static bike three times per week and/or three bouts of rIPC per week for 8 weeks.
A single bout of rIPC consists of cycles of upper arm cuff inflation for 5 minutes, followed by 5 minutes cuff deflation repeated 4 times.
|
|
Experimental: rIPC only
Those randomly allocated into the rIPC group will self administer 3 bouts of IPC per week at home at a time of their choice.
|
Three bouts of rIPC per week for 8 weeks.
A single bout of rIPC consists of cycles of upper arm cuff inflation for 5 minutes, followed by 5 minutes deflation repeated 4 times.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Changes in peripheral vascular function
Time Frame: Peripheral vascular function will be assessed before the intervention, after 2 weeks of the intervention and after the end of the 8 week intervention.
|
Flow mediated dilation will be used to assess endothelial-dependent vasodilation of the brachial artery.
|
Peripheral vascular function will be assessed before the intervention, after 2 weeks of the intervention and after the end of the 8 week intervention.
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Detect changes in cerebrovascular function
Time Frame: Cerebrovascular function will be assessed before the intervention, after 2 weeks of the intervention and after the end of the 8 week intervention.
|
Transcranial Doppler will be used to assess the cerebral blood flow response to changes in blood pressure, neural activity and breathing rate.
|
Cerebrovascular function will be assessed before the intervention, after 2 weeks of the intervention and after the end of the 8 week intervention.
|
|
Response to an ischemia re-perfusion injury
Time Frame: Assessments will be performed before the intervention, after 2 weeks of the intervention and after the end of the 8 week intervention.
|
Vascular response to an ischemia re-perfusion injury will be assessed in the upper arm using 15 minutes of cuff inflation to 200mmHg followed by 15 minutes of reperfusion.
The ability of the brachial artery to vasodilate will be used as a marker of reperfusion injury.
|
Assessments will be performed before the intervention, after 2 weeks of the intervention and after the end of the 8 week intervention.
|
|
Assessment of cardiorespiratory fitness
Time Frame: Cardiorespiratory fitness will be assessed before and after the 8 week intervention
|
This will involve assessment of cardiorespiratory fitness using a maximal oxygen uptake test on a treadmill.
Participants will be fitted with a heart rate monitor and face mask.
|
Cardiorespiratory fitness will be assessed before and after the 8 week intervention
|
Collaborators and Investigators
Sponsor
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- Exericse&rIPC
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.